HIGHLIGHTS
- who: Simone Lanini from the University and Verona, Verona, Italy, Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy. , AchilleS Vaccine, Siena, Italy. have published the Article: Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- what: The results of this study show that, following a single i.m. administration, MAD0004J08 at 48, 100, and 400 mg is safe, well tolerated with minimal reactogenic adverse events, and rapidly distributes systemically. The authors showed that sera from MAD0004J08 treated subjects retained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.